95 related articles for article (PubMed ID: 3051249)
1. [Myasthenia-multiple sclerosis: a possible pathogenetic relationship?].
De Meyer F; Maquet JC; Gyselings R
Rev Med Brux; 1988 Sep; 9(6):321-5. PubMed ID: 3051249
[No Abstract] [Full Text] [Related]
2. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
3. [Main histocompatibility HLA system antigens in myasthenia gravis].
Kastelan A; Jusić A
Neurologija; 1979; 27(1-4):155-62. PubMed ID: 262004
[No Abstract] [Full Text] [Related]
4. Workshop on HLA and disease.
Festenstein H; Nyulassy S
Transplant Proc; 1979 Mar; 11(1):1183-5. PubMed ID: 313097
[No Abstract] [Full Text] [Related]
5. [Immunosuppressive therapy of various autoimmune diseases of the nervous system].
Neretin VIa; Odinokova VA; Kir'iakov VA; Sapfirova VA
Sov Med; 1990; (12):31-5. PubMed ID: 2097756
[No Abstract] [Full Text] [Related]
6. [Association of Basedow's disease and myasthenia: apropos of a case].
Djedidi S; Ben Khalifa F; Kamoun S; Ayed K; Ben Ayed H
Tunis Med; 1981; 59(2):133-7. PubMed ID: 6894813
[No Abstract] [Full Text] [Related]
7. [Clinical, pathologic and HLA antigen markers of heterogeneity associated with myasthenia gravis].
Apostolski S; Krstić S; Gospavić J; Miletić V; Lazić D; Stolić I
Neurologija; 1985; 34(1-4):47-58. PubMed ID: 3836365
[No Abstract] [Full Text] [Related]
8. [Simultaneous occurrence of multiple sclerosis and myasthenia gravis].
Szobor A
Orv Hetil; 1984 May; 125(19):1127-9. PubMed ID: 6718000
[No Abstract] [Full Text] [Related]
9. [A case of multiple sclerosis occurred after thymectomy in myasthenia gravis].
Nakamura Y; Takahashi M; Yorifuji S; Hazama T; Taru S
Rinsho Shinkeigaku; 1986 Sep; 26(9):937-40. PubMed ID: 3791774
[No Abstract] [Full Text] [Related]
10. Contrasting defects of T-lymphocyte mitogenic response in multiple sclerosis and myasthenia gravis.
Richman DP; Dropcho EJ; Antel JP; Arnason BG
Trans Am Neurol Assoc; 1978; 103():191-3. PubMed ID: 316215
[No Abstract] [Full Text] [Related]
11. [Histocompatibility antigens in childhood myasthenia].
Uhrynowska M
Neurol Neurochir Pol; 1987; 21(2):119-24. PubMed ID: 3477704
[TBL] [Abstract][Full Text] [Related]
12. [Immunogenetic aspects of neuroimmunologic diseases].
Meyer-Rienecker HJ; Hitzschke B; Wegener S; Jenssen HL
Z Arztl Fortbild (Jena); 1983; 77(1):7-12. PubMed ID: 6845759
[No Abstract] [Full Text] [Related]
13. HLA antigens and susceptibility to myasthenia gravis.
Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
[TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis after BMT: identification of patients at risk?
Melms A; Faul C; Sommer N; Wiethölter H; Müller CA; Ehninger G
Bone Marrow Transplant; 1992 Jan; 9(1):78-9. PubMed ID: 1543956
[No Abstract] [Full Text] [Related]
15. Familial autoimmune myasthenia gravis.
Tan JH; Ho KH
Singapore Med J; 2001 Apr; 42(4):178-9. PubMed ID: 11465320
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiologic study of multiple sclerosis, myasthenia gravis and polymyositis in the city of Kumamoto, Japan].
Araki S; Uchino M; Yoshida O
Rinsho Shinkeigaku; 1983 Oct; 23(10):838-41. PubMed ID: 6673864
[No Abstract] [Full Text] [Related]
17. [Thymus-dependent therapeutic immunosuppression in multiple sclerosis and myasthenia].
Lobzin VS; Golovkin VI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):176-81. PubMed ID: 7072415
[TBL] [Abstract][Full Text] [Related]
18. Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis.
Link J; Fredrikson S; Söderström M; Olsson T; Höjeberg B; Ljungdahl A; Link H
Ann Neurol; 1994 Feb; 35(2):197-203. PubMed ID: 7509140
[TBL] [Abstract][Full Text] [Related]
19. Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia.
Isbister CM; Mackenzie PJ; Anderson D; Wade NK; Oger J
Mult Scler; 2003 Dec; 9(6):550-3. PubMed ID: 14664466
[TBL] [Abstract][Full Text] [Related]
20. Interferon causes no myasthenia in a seropositive patient with multiple sclerosis.
Shimizu H; Kataoka H; Kawahara M; Hirano M; Furiya Y; Ueno S
Clin Neurol Neurosurg; 2007 Apr; 109(3):277-8. PubMed ID: 17118531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
